OKLAHOMA CITY — A doctor who examined the body of an Oklahoma inmate who died during a botched execution told a federal judge Wednesday that he is convinced the man suffered after being declared unconscious.
Dr. Joseph Cohen, a pathologist hired by the inmate's lawyer, said that recently released witness statements corroborate his belief that Clayton Lockett was conscious when given drugs to stop his heart and breathing. Several witnesses, including an Associated Press reporter, saw the inmate struggle against his restraints, mumble and try to raise his head.
"Mr. Lockett had been deemed unconscious but became conscious again," Cohen testified at a hearing on whether Oklahoma should resume executions Jan. 15 after a self-imposed moratorium. Death row inmates say they fear the state is conducting human experiments on them by using newly approved drug combinations during executions.
The state maintains that Lockett's problematic execution was an anomaly caused by an improperly set intravenous line and not the result of using the sedative midazolam as the first in a three-drug combination.
Assistant Attorney General John Hadden said Oklahoma and other states have been forced to look for other drug alternatives after more commonly used short-acting barbiturates became scarce because of manufacturers' opposition to the death penalty.
Oklahoma was the first state ever to use 100 milligrams of midazolam as part of a three-drug protocol during Lockett's execution. Florida has used 500 milligrams, the level Oklahoma's new protocol calls for using.
But a Florida anesthesiologist, Dr. David Lubarsky, testified that midazolam has a ceiling effect, and that increasing the dose does not increase the effect. He also said it's used mostly to calm a patient before a surgery, and not as an anesthetic that produces unconsciousness.
"It's simply not strong enough to reduce all electrical activity in the brain," Lubarsky said.